Cannabis Stocks vs Alcohol / Beverage Stocks: Which Is Better for Cannabis Investors?
Cannabis Stocks
Publicly traded cannabis companies including MSOs, LPs, REITs, and ancillary operators. A young, high-growth sector facing regulatory uncertainty, limited institutional participation, and evolving consumer adoption. Potential for outsized returns but with significant volatility.
Alcohol / Beverage Stocks
Established companies in the alcoholic beverage industry — brewers, distillers, and wine producers like Constellation Brands, Diageo, AB InBev, and Molson Coors. Mature industry with stable margins, dividends, institutional ownership, and decades of predictable consumer demand.
Quick Comparison
| Metric | Cannabis Stocks | Alcohol / Beverage Stocks |
|---|---|---|
| Industry Maturity | Emerging (5-10 years public) | Mature (100+ years) |
| Revenue Scale | $1-4B (top companies) | $10-60B (top companies) |
| Gross Margins | 40-55% | 50-65% |
| Dividend Yield | None (growth stage) | 1.5-4% typical |
| Volatility | Extreme (50-80% annual swings) | Moderate (10-20%) |
| Federal Legal Status | Illegal (US) / Legal (Canada) | Fully legal globally |
| Institutional Ownership | Limited | Extensive (index inclusion) |
| Growth Rate | 15-30%+ (sector CAGR) | 2-5% (steady, mature) |
Detailed Comparison
Comparing cannabis stocks to alcohol stocks illustrates the difference between investing in an emerging, regulatory-constrained industry and an established, fully legal sector. The parallels between the two substances as consumer products make this comparison particularly informative for investors weighing risk versus maturity.
The alcohol industry is a textbook mature sector. Major producers like Constellation Brands, Diageo, and AB InBev generate tens of billions in annual revenue with predictable growth rates, robust margins, and substantial dividends. These companies have traded publicly for decades, are held by every major institutional investor, and are components of major market indices. Share price volatility is modest — annual price swings of 10-20% are typical. The business model is well understood and the regulatory framework (post-Prohibition) has been stable for nearly a century.
Cannabis stocks exist in a fundamentally different phase of industry development. The largest cannabis companies generate $1-4 billion in annual revenue — meaningful but dwarfed by alcohol peers. Growth rates are higher (the industry is still expanding), but so is uncertainty around regulatory timelines, tax treatment, and competitive structure. Cannabis stocks have experienced drawdowns of 70-90% from peak to trough, far exceeding the worst periods for alcohol stocks. Institutional participation is limited by federal prohibition, and no cannabis company is in a major stock index.
The margin comparison is evolving. Alcohol companies enjoy gross margins of 50-65% and net margins of 15-25% — among the highest of any consumer product category. Cannabis gross margins for the best operators range from 40-55%, which is competitive, but Section 280E taxation in the US devastates net margins. If 280E is eliminated through rescheduling, the profitability profile of US cannabis companies could rapidly approach that of alcohol companies, making this comparison more favorable for cannabis.
One of the most discussed themes in this comparison is substitution — whether cannabis consumption is taking share from alcohol. Survey data and state-level sales data suggest meaningful overlap: in states that have legalized recreational cannabis, alcohol sales growth has slowed relative to non-legal states. If this substitution trend continues, cannabis companies could capture a meaningful share of the $260+ billion global alcohol market. Several alcohol companies have recognized this risk/opportunity — Constellation Brands invested billions in Canopy Growth, and Molson Coors launched cannabis-related beverage ventures.
From an ESG and regulatory perspective, alcohol has a mature regulatory framework that creates high barriers to entry and ensures market stability. Cannabis regulation is evolving rapidly, creating both opportunity (first-mover advantages in new markets) and risk (rules can change). Social acceptance of cannabis continues to increase, narrowing the gap with alcohol, but cannabis still faces stigma and restrictions that alcohol does not, including federal banking limitations, advertising restrictions, and workplace drug testing policies.
The Verdict
Alcohol stocks are the clear choice for conservative investors seeking stable returns, dividends, and low volatility. Cannabis stocks offer dramatically higher upside potential for risk-tolerant investors who believe in the long-term growth of legal cannabis — particularly if federal reform unlocks institutional capital and eliminates 280E taxation. As the cannabis industry matures, the two sectors may eventually converge in character, but today they serve very different portfolio roles: alcohol for stability and income, cannabis for growth and optionality.
Which Stocks to Consider
Frequently Asked Questions
Is cannabis replacing alcohol among consumers?
Data suggests meaningful substitution is occurring. In states with legal recreational cannabis, alcohol sales growth has slowed. Surveys show that younger demographics (21-35) are increasingly choosing cannabis over alcohol. However, complete replacement is unlikely — the two substances serve different social functions and many consumers use both. The substitution trend is most pronounced for beer and spirits among younger consumers.
Will cannabis stocks eventually look like alcohol stocks?
As the cannabis industry matures, companies will likely develop characteristics similar to alcohol companies — stable revenue, reliable margins, dividends, and moderate growth. This transition could accelerate with federal legalization, which would normalize institutional ownership and capital market access. However, full maturation will take years, and the industry must first navigate the transition from state-by-state fragmentation to a potentially national market.
Which alcohol companies have cannabis investments?
Constellation Brands (STZ) made a landmark $4 billion investment in Canopy Growth (CGC) in 2018, though the investment has generated significant losses. Molson Coors partnered with HEXO Corp for cannabis beverages. AB InBev explored cannabis beverage partnerships. These investments reflect alcohol industry awareness that cannabis poses both a competitive threat and a growth opportunity.
Should I own both cannabis and alcohol stocks?
Owning both provides interesting portfolio dynamics. Alcohol stocks offer stability, dividends, and defensive characteristics. Cannabis stocks offer growth, optionality on federal reform, and exposure to a secular shift in consumer preferences. If cannabis continues to capture share from alcohol, having positions in both sectors provides a natural hedge — your cannabis gains offset any alcohol headwinds, and vice versa.
Related Comparisons
Disclaimer: This comparison is for educational and informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Cannabis investing carries significant risks including regulatory uncertainty, market volatility, and the potential for total loss of capital. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Data shown is sourced from publicly available information and may not be complete or current.